What is Dermala?
Dermala offers a personalized approach to acne treatment by leveraging the human microbiome and data analytics to enhance skin health. The company's product line encompasses supplements, cleansers, moisturizers, and treatment pads, all designed to combat acne from both internal and external factors. By providing customized treatment kits based on personal skin assessments, Dermala targets individuals seeking effective solutions for acne. The company's philosophy centers on achieving a balanced internal ecosystem as a key to addressing persistent acne issues.
How much funding has Dermala raised?
Dermala has raised a total of $6.7M across 1 funding round:
Series A
$6.7M
Series A (2020): $6.7M with participation from Cove Fund II, Seventure Partners, JJDC, and True Wealth Ventures
Key Investors in Dermala
Cove Fund II
Cove Fund II is an investment vehicle focused on transforming home ownership through innovative financing programs. While their primary domain is mortgage alternatives, their participation in Dermala's funding suggests an interest in companies that offer unique consumer solutions.
Seventure Partners
Seventure Partners is a venture capital firm actively investing in innovative companies within life sciences and digital technologies. Their focus on health and biotechnology aligns well with Dermala's microbiome-based approach to skincare.
JJDC
While JJDC's primary domain is educational services, their investment in Dermala may indicate a broader interest in disruptive technologies or a strategic partnership opportunity within the health and wellness sector.
What's next for Dermala?
With the recent infusion of major strategic capital, Dermala is poised to accelerate its product development and expand its market reach. The company's focus on personalized, microbiome-driven acne solutions positions it advantageously in the growing dermo-cosmetics and personalized health markets. Future endeavors will likely involve scaling production, enhancing data-driven personalization algorithms, and potentially exploring new therapeutic areas beyond acne, building on their foundational expertise in skin health and the microbiome.
See full Dermala company page
